BenzingaAugust 12, 2026 at 8:00 AM NY2 Months Ago
Wedbush Maintains Outperform on Zura Bio, Raises Price Target to $22
Wedbush analyst Martin Fan maintains Zura Bio (NASDAQ:ZURA) with a Outperform and raises the price target from $15 to $22.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
